Equetro Shire Pharmaceuticals Group plc - Treatment for Bipolar Disorder
Equetro, previously known as SPD417, is indicated for the treatment
of acute manic and mixed episodes associated with Bipolar I
Disorder. Equetro will be available for prescribing in the US in
the first quarter of 2005.
Posted: December 2004
Equetro (carbamazepine) FDA Approval History